Dec. 17, 2007 — -- A test to determine a woman's genetic makeup may predict whether she is likely to benefit from the commonly prescribed breast cancer drug Tamoxifen, according to a study ...
An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can increase the risk of secondary tumors in the uterus. Subscribe to our ...